Maternal serum advanced glycation end products level as an early marker for predicting preterm labor/PPROM: a prospective preliminary study

References

• Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116(7):1793–1801.
   PubMed Web of Science ®Google Scholar
• Peppa M, Vlassara H. Advanced glycation end products and diabetic complications: a general overview. Hormones (Athens). 2005;4(1):28–37.
   PubMedGoogle Scholar
• Stirban A, Gawlowski T, Roden M. Vascular effects of advanced glycation end products: clinical effects and molecular mechanisms. Mol Metab. 2014;3(2):94–108.
   PubMed Web of Science ®Google Scholar
• Fu MX, Requena JR, Jenkins AJ, et al. The advanced glycation end product, N ε-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem. 1996;271(17):9982–9986.
   PubMed Web of Science ®Google Scholar
• Kasper M, Schieberle P. Labeling STUDIES on the formation pathway of N ε-carboxymethyllysine in Maillard-type reactions. Ann NY Acad Sci. 2005;1043(1):59–62.
   PubMed Web of Science ®Google Scholar
• Westwood ME, Argirov OK, Abordo EA, et al. Methylglyoxal-modified arginine residues – a signal for receptor-mediated endocytosis and degradation of proteins by monocytic THP-1 cells. Biochim Biophys Acta. 1997;1356(1):84–94.
   PubMed Web of Science ®Google Scholar
• Berbaum K, Shanmugam K, Stuchbury G, et al. Induction of novel cytokines and chemokines by advanced glycation endproducts determined with a cytometric bead array. Cytokine. 2008;41(3):198–203.
   PubMed Web of Science ®Google Scholar
• Barile GR, Pachydaki SI, Tari SR, et al. The RAGE axis in early diabetic retinopathy. Invest Ophthalmol Vis Sci. 2005;46(8):2916–2924.
   PubMed Web of Science ®Google Scholar
• Yonekura H, Yamamoto Y, Sakurai S, et al. Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury. J Pharmacol Sci. 2005;97(3):305–311.
   PubMed Web of Science ®Google Scholar
• Kalea AZ, Schmidt AM, Hudson BI. RAGE: a novel biological and genetic marker for vascular disease. Clin Sci (Lond). 2009;116(8):621–637.
   PubMed Web of Science ®Google Scholar
• Yu Y, Hanssen KF, Kalyanaraman V, et al. Reduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetes. BJOG. 2012;119(12):1512–1520.
   PubMed Web of Science ®Google Scholar
• Sultana Z, Maiti K, Aitken J, et al. Oxidative stress, placental ageing-related pathologies and adverse pregnancy outcomes. Am J Reprod Immunol. 2017;77(5).
   PubMed Web of Science ®Google Scholar
• Jamilian M, Hashemi Dizaji S, Bahmani F, et al. A randomized controlled clinical trial investigating the effects of Omega-3 fatty acids and vitamin E co-supplementation on biomarkers of oxidative stress, inflammation and pregnancy outcomes in gestational diabetes. Can J Diabetes. 2017;41(2):143–149.
   PubMed Web of Science ®Google Scholar
• Dutta EH, Behnia F, Boldogh I, et al. Oxidative stress damage-associated molecular signaling pathways differentiate spontaneous preterm birth and preterm premature rupture of the membranes. Mol Hum Reprod. 2016;22(2):143–157.
   PubMed Web of Science ®Google Scholar
• Wu F, Tian FJ, Lin Y, et al. Oxidative stress: placenta function and dysfunction. Am J Reprod Immunol. 2016;76(4):258–271.
   PubMed Web of Science ®Google Scholar
• Harsem NK, Braekke K, Torjussen T, et al. Advanced glycation end products in pregnancies complicated with diabetes mellitus or preeclampsia. Hypertens Pregnancy. 2008;27(4):374–386.
   PubMed Web of Science ®Google Scholar
• Xian N, Chen W, Zhang Y, et al. Correlation of the expressions of advanced glycation end products and its receptor in serum and placenta with the pathogenesis of preeclampsia. Zhonghua Fu Chan Ke Zhi. 2015;50(7):493–499.
   PubMedGoogle Scholar
• Chen W, Zhang Y, Yue C, et al. Accumulation of advanced glycation end products involved in inflammation and contributing to severe preeclampsia, in maternal blood, umbilical blood and placental tissues. Gynecol Obstet Invest. 2017;82(4):388–397.
   PubMed Web of Science ®Google Scholar
• Vlassara H, Uribarri J. Advanced glycation end products (AGE) and diabetes: cause, effect, or both? Curr Diab Rep. 2014;14(1):453.
   PubMed Web of Science ®Google Scholar
• Spong CY. Defining “term” pregnancy: recommendations from the Defining “Term” Pregnancy Workgroup. JAMA. 2013;309(23):2445–2446.
   PubMed Web of Science ®Google Scholar
• Practice bulletins No. 139: premature rupture of membranes. Obstet Gynecol. 2013;122(4):918–930. DOI:10.1097/01.AOG.0000435415.21944.8f
   PubMedGoogle Scholar
• Loftin RW, Habli M, Snyder CC, et al. Late preterm birth. Rev Obstet Gynecol. 2010;3(1):10–19.
   PubMedGoogle Scholar
• Otsubo Y, Hashimoto K, Kanbe T, et al. Association of cord blood chemokines and other biomarkers with neonatal complications following intrauterine inflammation. PLoS ONE. 2017;12(5):e0175082.
   PubMed Web of Science ®Google Scholar
• Menon R, Fortunato SJ. Infection and the role of inflammation in preterm premature rupture of the membranes. Best Pract Res Clin Obstet Gynaecol. 2007;21(3):467–478.
   PubMed Web of Science ®Google Scholar
• Boyle AK, Rinaldi SF, Norman JE, et al. Preterm birth: inflammation, fetal injury and treatment strategies. J Reprod Immunol. 2017;119:62–66.
   PubMed Web of Science ®Google Scholar
• Menon R, Richardson LS. Preterm prelabor rupture of the membranes: a disease of the fetal membranes. Semin Perinatol. 2017;41(7):409–419.
   PubMed Web of Science ®Google Scholar
• Higai K, Shimamura A, Matsumoto K. Amadori-modified glycated albumin predominantly induces E-selectin expression on human umbilical vein endothelial cells through NADPH oxidase activation. Clin Chim Acta. 2006;367(1–2):137–143.
   PubMed Web of Science ®Google Scholar
• Noguchi T, Sado T, Naruse K, et al. Evidence for activation of Toll-like receptor and receptor for advanced glycation end products in preterm birth. Mediators Inflamm. 2010;2010:490406.
   PubMed Web of Science ®Google Scholar
• Ramasamy R, Vannucci SJ, Yan SS, et al. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology. 2005;15(7):16R–28R.
   PubMed Web of Science ®Google Scholar
• Schmidt AM, Yan SD, Yan SF, et al. The biology of the receptor for advanced glycation end products and its ligands. BBA – Mol Cell Res. 2000;1498(2–3):99–111.
   PubMed Web of Science ®Google Scholar
• Romero R, Chaiworapongsa T, Savasan ZA, et al. Clinical chorioamnionitis is characterized by changes in the expression of the alarmin HMGB1 and one of its receptors, sRAGE. J Matern Fetal Neonatal Med. 2012;25(6):558–567.
   PubMed Web of Science ®Google Scholar
• Papagrigoraki A, Del Giglio M, Cosma C, et al. Advanced glycation end products are increased in the skin and blood of patients with severe psoriasis. Acta Derm Venereol. 2017;97(7):782–787.
   PubMed Web of Science ®Google Scholar
• Yan JY, Jiang LL. Expression of advanced glycation end products in placenta and concentration in maternal and umbilical serum in pre-eclampsia. J Obstet Gynaecol Res. 2015;41(6):843–849.
   PubMed Web of Science ®Google Scholar
• Luévano-Contreras C, Garay-Sevilla ME, Wrobel K, et al. Dietary advanced glycation end products restriction diminishes inflammation markers and oxidative stress in patients with type 2 diabetes mellitus. J Clin Biochem Nutr. 2013;52(1):22–26.
   PubMed Web of Science ®Google Scholar
• Nagai R, Shirakawa J, Ohno R, et al. Inhibition of AGEs formation by natural products. Amino Acids. 2014;46(2):261–266.
   PubMed Web of Science ®Google Scholar
• Peyroux J, Sternberg M. Advanced glycation endproducts (AGEs): pharmacological inhibition in diabetes. Pathol Biol (Paris). 2006;54(7):405–419.
   PubMedGoogle Scholar
• Younessi P, Yoonessi A. Advanced glycation end-products and their receptor-mediated roles: inflammation and oxidative stress. Iran J Med Sci. 2011;36(3):154–166.
   PubMedGoogle Scholar